Recently, appointed by the Veterinary Bureau of the Agriculture and Animal Husbandry Department of Inner Mongolia, the expert team of Yang Dongmei, Ren Wanjun, Liu Xiaodan and Liu Min, together with Liu Xingliang and Wang Xia from the Bayannur Veterinary Bureau, acted as on-site observers, and carried out a two-day inspection and acceptance of the production license and GMP of tylosin tartrate veterinary drugs for the United Laboratories (Inner Mongolia) Co., Ltd. The company leaders and relevant personnel received and accompanied the inspection process.
This inspection is mainly conducted online by the expert group of the autonomous region, with observers from the Bayannur Veterinary Bureau conducting offline inspections and confirmations, combining online and offline methods. This acceptance method is not only the first time the company has undergone official inspection online, but also the first time the autonomous region expert group has conducted online inspection and acceptance of production enterprises in the autonomous region. It is a huge challenge for the company to ensure the smooth progress of inspection and acceptance work under limited epidemic prevention and control conditions.
Before the inspection, the relevant departments of the company continuously conducted network debugging on the workshops and departments involved in the inspection and acceptance, and conducted multiple online simulation inspections. Each unit continuously improves and cooperates with each other, making full preparations to ensure the smooth progress of online inspection and acceptance.
During the acceptance period, the expert group strictly followed the relevant requirements and regulations of the "Quality Management Standards for Veterinary Medicine Production" (revised in 2020) and the "Standards for Inspection, Acceptance and Review of Quality Management Standards for Veterinary Medicine Production" (revised in 2020) to conduct a comprehensive, strict, and meticulous inspection and acceptance of the company's Tartrate Tylosin production line, from factory equipment, quality control to documents and records.
Through inspection, the expert group affirmed the company's full preparation and professional ability. At the same time, valuable suggestions were put forward on how enterprises can continue to improve and improve the implementation level of the new version of GMP for veterinary drugs. At the final meeting, after discussion and evaluation by the expert group, the non sterile raw material drug (Tylosin Tartrate) production line successfully passed the veterinary drug production license and GMP inspection and acceptance.
The company will continue to strictly follow the quality management standards for veterinary drug production in production and quality management. The smooth passing of the production license and GMP acceptance of Tylosin Tartrate veterinary medicine this time marks a new level for TUL of Inner Mongolian, providing strong guarantees for producing high-quality products and laying a more solid foundation for enhancing market competitiveness.
(All Rights Reserved)